278 related articles for article (PubMed ID: 29651970)
1. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
[TBL] [Abstract][Full Text] [Related]
2. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
3. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
[TBL] [Abstract][Full Text] [Related]
4. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
5. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
[TBL] [Abstract][Full Text] [Related]
6. Effects of Boron-Based Gel on Radiation-Induced Dermatitis in Breast Cancer: A Double-Blind, Placebo-Controlled Trial.
Aysan E; Idiz UO; Elmas L; Saglam EK; Akgun Z; Yucel SB
J Invest Surg; 2017 Jun; 30(3):187-192. PubMed ID: 27700210
[TBL] [Abstract][Full Text] [Related]
7. Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial.
Talakesh T; Tabatabaee N; Atoof F; Aliasgharzadeh A; Sarvizade M; Farhood B; Najafi M
Curr Radiopharm; 2022; 15(4):332-340. PubMed ID: 35747962
[TBL] [Abstract][Full Text] [Related]
8. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
[TBL] [Abstract][Full Text] [Related]
10. Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.
Sekiguchi K; Ogita M; Akahane K; Haga C; Ito R; Arai S; Ishida Y; Tsukada Y; Kawamori J
Jpn J Clin Oncol; 2015 Dec; 45(12):1146-53. PubMed ID: 26491204
[TBL] [Abstract][Full Text] [Related]
11. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial.
Karbasforooshan H; Hosseini S; Elyasi S; Fani Pakdel A; Karimi G
Phytother Res; 2019 Feb; 33(2):379-386. PubMed ID: 30479044
[TBL] [Abstract][Full Text] [Related]
12. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.
Ryan JL; Heckler CE; Ling M; Katz A; Williams JP; Pentland AP; Morrow GR
Radiat Res; 2013 Jul; 180(1):34-43. PubMed ID: 23745991
[TBL] [Abstract][Full Text] [Related]
13. Effect of melatonin cream on acute radiation dermatitis in patients with primary breast cancer: A double-blind, randomized, placebo-controlled trial.
Zetner D; Kamby C; Christophersen C; Gülen S; Paulsen CB; Piga E; Hoffmeyer B; Mahmood F; Rosenberg J
J Pineal Res; 2023 Aug; 75(1):e12873. PubMed ID: 37055944
[TBL] [Abstract][Full Text] [Related]
14. Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients.
Ryan Wolf J; Heckler CE; Guido JJ; Peoples AR; Gewandter JS; Ling M; Vinciguerra VP; Anderson T; Evans L; Wade J; Pentland AP; Morrow GR
Support Care Cancer; 2018 May; 26(5):1543-1552. PubMed ID: 29192329
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U
Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066
[TBL] [Abstract][Full Text] [Related]
16. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
17. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
18. Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial.
Chan RJ; Mann J; Tripcony L; Keller J; Cheuk R; Blades R; Keogh S; Poole C; Walsh C
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):756-64. PubMed ID: 25151541
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.
Zhu W; Jia L; Chen G; Zhao H; Sun X; Meng X; Zhao X; Xing L; Yu J; Zheng M
Oncotarget; 2016 Jul; 7(30):48607-48613. PubMed ID: 27224910
[TBL] [Abstract][Full Text] [Related]
20. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.
Szumacher E; Wighton A; Franssen E; Chow E; Tsao M; Ackerman I; Andersson L; Kim J; Wojcicka A; Ung Y; Sixel K; Hayter C
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):81-6. PubMed ID: 11516855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]